Related Experiment Video
Updated: Aug 10, 2026
10:16
In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
alpha1-Antitrypsin deficiency in clinic patients
Annals of Clinical Research
|April 1, 1977
Summary
Alpha-1 antitrypsin deficiency variants were more common in patients with respiratory disease. Heterozygosity for these variants was also linked to increased respiratory illness in a study of over 700 patients.
Area of Science:
- Pulmonary Medicine
- Genetics
- Clinical Diagnostics
Background:
- Alpha-1 antitrypsin deficiency is a genetic condition that can lead to lung disease.
- Pi phenotypes represent variations in alpha-1 antitrypsin, with MM being the most common.
- Understanding the association between variant phenotypes and respiratory disease is crucial for early diagnosis and management.
Purpose of the Study:
- To investigate the association between alpha-1 antitrypsin deficiency Pi phenotypes and the incidence of respiratory disease.
- To determine if heterozygosity for alpha-1 antitrypsin deficiency variants is more frequent in patients with respiratory conditions.
Main Methods:
- Studied 500 patients undergoing medical examination and 225 patients with abnormal pulmonary function tests.
- Assessed patients for alpha-1 antitrypsin deficiency and analyzed Pi phenotypes (MM, MS, MZ, FF).
- Compared the frequency of variant phenotypes and heterozygosity in patients with and without respiratory disease.
Main Results:
- Respiratory disease was diagnosed more frequently in patients with variant Pi phenotypes (MS, MZ, FF) compared to the common MM phenotype.
- A higher frequency of heterozygosity (MS or MZ) was observed in patients diagnosed with respiratory disease.
- No statistically significant difference in variant phenotype prevalence was found when comparing patients with general medical exams to those with abnormal pulmonary function tests.
Conclusions:
- Variant alpha-1 antitrypsin deficiency Pi phenotypes are associated with a higher risk of respiratory disease.
- Heterozygosity for alpha-1 antitrypsin deficiency may increase susceptibility to respiratory conditions.
- Further research is warranted to elucidate the clinical significance of these findings in diverse patient populations.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...